4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-18-063963
Chief Executive Officer sold 90,000 shares at $13.92 ($1,252,800)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anzalone Christopher Richard Chief Executive Officer | 2018-12-19 | Sale | −90,000 | $13.92 | $1,252,800 | 1,542,455 | D |
| Open-market sales · 90,000 sh · avg $13.92 · $1,252,800 | |||||||
Loading xslF345X03/doc4.xml…